Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston
4
×
boston blog main
boston top stories
editas medicine
4
×
life sciences
national blog main
crispr
gene editing
allergan
broad institute
clinical trials
cynthia collins
david liu
national top stories
san francisco blog main
abbvie
agios therapeutics
alzheimer's disease
base editing
beam therapeutics
biotech week boston
branden moriarty
bristol-myers squibb
bwb
cancer
cas13
cindy perettie
crispr therapeutics
crispr-cas9
deals
dna
drugs
editor
editr
enzyme
feng zhang
foundation medicine
harvard university
immuno-oncology
What
editas
editing
gene
medicine
crispr
experimental
abbvie
allergan
alliance
beam
benefiting
biotech
blessing
bosley
boston
cas
ceo
check
clinical
coming
cusp
depart
diagnostics
editor
exits
founders
genetic
glimcher
gotten
groundbreaking
harvard
headline
humans
jump
katrine
keynote
laurie
market
mass
medicines
Language
unset
Current search:
boston
×
biotech
×
" editas medicine "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M